Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > The “new strategy”
View:
Post by Bucknelly21 on Jul 14, 2021 10:06am

The “new strategy”

I think the new strategy is to engage the market less, in that case they are on fire...
Comment by Wino115 on Jul 14, 2021 10:57am
My guess is that since the only 3 analysts that cover it do not focus on the pipeline as the huge value creator and instead still fret over quarterly revenues and EBITDA, they expect higher costs no an earnings miss off their ridiculously high expectations.  Since there's no valuation anchoring to the pipeline at this point (or a mild one if you assume the $1+ in option value for SORT1 ...more  
Comment by Bucknelly21 on Jul 14, 2021 11:14am
agree and it appears that they were just giving you some ear candy lol 
Comment by mikeq113 on Jul 14, 2021 10:58am
I just don't understand their logic as it pertains to marketing, communications and the investment community at all.  They just went out and presumably spent a decent amount of money to get LSA involved and the only signs of this have been a revamped website (long overdue) and a KOL event that created some buzz and a short-term bounce in the stock price followed by defeaning silence for ...more  
Comment by canadapiet on Jul 14, 2021 11:06am
All their "pr's" helped very well!!!  Look at the volume................, more than 100 shares.....!!!! How in the world could i have sold my 9.500 shares for 4,80 ????? Hope tomorow will be good ER.... luck and hope for all 
Comment by SPCEO1 on Jul 14, 2021 12:49pm
WHile TH is a Canadian comapny it is no longer much of a Canadian stock as most of the trading volume is now in the US on NASDAQ. Most of the shareholders are also US based at this point too. So, if you want to trade your stock, you should have no problem trading it easily in the US on NASDAQ.
Comment by canadapiet on Jul 14, 2021 2:28pm
Hello Mr. SPCEO1,  i wish i could, but my bank won't let me do that. Only can buy and sell on Toronto market (unbelievable but the truth)! But i also have an account at an internet broker where i have shares on the Nasdaq. But my point was with that low volume i still could sell my shares in one package, so i think someone is accumulating. Am waiting what tomorrow brings to eventualy ...more  
Comment by qwerty22 on Jul 14, 2021 11:24am
The only advice is to steel yourself for a few more weeks of deafening silence, something might happen in the summer but it looks like Fall is when a number of things start to get resolved (hopefully).  
Comment by jfm1330 on Jul 14, 2021 11:38am
They cannot invent news and publish press releases out of nothing. This period reminds me of the long wait for ibalizumab (Trogarzo) approval. It was long, with an added delay by the FDA, we were complaining that the market was not recognizing the fact that the approval was almost sure. Then, the approval finally came, and the stock price rose significantly. We all know what happened after that ...more  
Comment by scarlet1967 on Jul 14, 2021 1:32pm
All R&D programs are valued  based on "projections" or probability of success, this applies to all those highly valued companies. Many have high visibility thanks to their efforts to get the attention of the market. That visibility create speculative investing pushing the valuation higher in anticipation of success. As for THTX due to the low profile, lack of clear and ongoing ...more  
Comment by qwerty22 on Jul 14, 2021 2:29pm
SPCEO too long ago to remember spotted that the company was going through a transition. Like it or not (mostly not) that process has put the company in the wilderness where they've wandered for 40 weeks and 40 more weeks and yet another 40 weeks. And we've had the misfortune to wander with them. And now, at some point in the 2nd half of 2021 they might just reach the Promised Land ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities